Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Daily News

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

L.A. McKeown

December 12, 2024

News Conference News ISET 2023

BioMimics 3D Stent Holds Up Well at 3 Years in Complex PAD Lesions

Caitlin E. Cox

January 20, 2023

News Daily News

IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document

L.A. McKeown

August 05, 2022

News Daily News

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

L.A. McKeown

September 17, 2020

News Conference News TCT 2019

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

L.A. McKeown

September 28, 2019

News Daily News

US Data Convey the Scope of Bleeding in Lower-Extremity Peripheral Interventions

Caitlin E. Cox

June 18, 2019

News Conference News SCAI 2019

Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics

Yael L. Maxwell

May 21, 2019

News Daily News

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

L.A. McKeown

January 25, 2019

News Daily News

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

L.A. McKeown

January 23, 2019

News Daily News

No Benefits, Higher Costs With IVC Filters in Catheter-Directed Thrombolysis for DVT

Michael O'Riordan

July 23, 2018

News Daily News

RANGER-SFA Data Support Another Paclitaxel-Coated Balloon for Superficial Femoral Artery Disease

L.A. McKeown

May 08, 2018

News Industry News

Medtronic IN.PACT(TM) Admiral(TM) Drug Coated Balloon Receives FDA Approval to Treat Long SFA Lesions

April 24, 2018

News Daily News

Same-Day Discharge After Peripheral Interventions Gets Mixed Results in Pilot Study

Todd Neale

March 22, 2018

News Conference News VIVA 2017

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

L.A. McKeown

September 18, 2017

News Conference News VIVA 2017

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

L.A. McKeown

September 13, 2017

News Daily News

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

L.A. McKeown

August 03, 2017

News Daily News

EUCLID: Ticagrelor Holds No Edge Over Clopidogrel for Preventing Atherothrombotic Events in Symptomatic PAD Patients

Shelley Wood

October 07, 2016

News Industry News

Essential Medical Inc. Announces FDA Approval to Begin a U.S. Clinical Trial for the MANTA™ Large Bore Vascular Closure Device

July 08, 2016

News Industry News

Shockwave Medical Announces Positive Study Results of Novel Lithoplasty System to Treat Peripheral Artery Disease

April 27, 2016

News Daily News

Paradoja Campeau: ¿Sacrifica el Abordaje Radial la Competencia Femoral?

L.A. McKeown

November 24, 2015

Advertisement

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

BioMimics 3D Stent Holds Up Well at 3 Years in Complex PAD Lesions

IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

US Data Convey the Scope of Bleeding in Lower-Extremity Peripheral Interventions

Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

No Benefits, Higher Costs With IVC Filters in Catheter-Directed Thrombolysis for DVT

RANGER-SFA Data Support Another Paclitaxel-Coated Balloon for Superficial Femoral Artery Disease

Medtronic IN.PACT(TM) Admiral(TM) Drug Coated Balloon Receives FDA Approval to Treat Long SFA Lesions

Same-Day Discharge After Peripheral Interventions Gets Mixed Results in Pilot Study

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

EUCLID: Ticagrelor Holds No Edge Over Clopidogrel for Preventing Atherothrombotic Events in Symptomatic PAD Patients

Essential Medical Inc. Announces FDA Approval to Begin a U.S. Clinical Trial for the MANTA™ Large Bore Vascular Closure Device

Shockwave Medical Announces Positive Study Results of Novel Lithoplasty System to Treat Peripheral Artery Disease

Paradoja Campeau: ¿Sacrifica el Abordaje Radial la Competencia Femoral?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content